ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
104 hedge funds and large institutions have $74.3M invested in Endocyte, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% less capital invested
Capital invested by funds: $85.5M → $74.3M (-$11.2M)
Holders
104
Holding in Top 10
–
Calls
$661K
Puts
$672K
Top Buyers
| 1 | +$6.21M | |
| 2 | +$631K | |
| 3 | +$492K | |
| 4 |
Axa
Paris,
France
|
+$408K |
| 5 |
Millennium Management
New York
|
+$329K |
Top Sellers
| 1 | -$2.78M | |
| 2 | -$1.44M | |
| 3 | -$1.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.1M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$964K |